Gene · 4070
Papers3,230
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,021 to 1,040 of 3,230
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Robust dimethyl-based multiplex-DIA doubles single-cell proteome depth via a reference channel. | Mol Syst Biol | 2023 | 37602975 | PubTator, text mining | PubMed |
| The Evolving Landscape of Immune Checkpoint Inhibitors and Antibody Drug Conjugates in the Treatment of Early-Stage Breast Cancer. | Oncologist | 2023 | 37597245 | PubTator, text mining | PubMed |
| Heimdall, an alternative protein issued from a ncRNA related to kappa light chain variable region of immunoglobulins from astrocytes: a new player in neural proteome. | Cell Death Dis | 2023 | 37587118 | PubTator, text mining | PubMed |
| Long-term benefit of immunotherapy in metastatic non-small cell lung cancer: the tale of the tail. | Transl Lung Cancer Res | 2023 | 37577318 | PubTator, text mining | PubMed |
| High levels of expression of Trop-2 in thymic epithelial tumors. | Lung Cancer | 2023 | 37573703 | PubTator, text mining | PubMed |
| Advances in the Management of Early-Stage Triple-Negative Breast Cancer. | Int J Mol Sci | 2023 | 37569851 | PubTator, text mining | PubMed |
| Combined Salivary Proteome Profiling and Machine Learning Analysis Provides Insight into Molecular Signature for Autoimmune Liver Diseases Classification. | Int J Mol Sci | 2023 | 37569584 | PubTator, text mining | PubMed |
| Antibody-Drug Conjugates for Breast Cancer Treatment: Emerging Agents, Targets and Future Directions. | Int J Mol Sci | 2023 | 37569276 | PubTator, text mining | PubMed |
| Antibody-Drug Conjugates: A Review of Approved Drugs and Their Clinical Level of Evidence. | Cancers (Basel) | 2023 | 37568702 | PubTator, text mining | PubMed |
| Systemic Therapy for Metastatic Triple Negative Breast Cancer: Current Treatments and Future Directions. | Cancers (Basel) | 2023 | 37568617 | PubTator, text mining | PubMed |
| Epigenetically upregulating TROP2 and SLFN11 enhances therapeutic efficacy of TROP2 antibody drug conjugate sacitizumab govitecan. | NPJ Breast Cancer | 2023 | 37567892 | PubTator, text mining | PubMed |
| Triple negative breast cancer metastasis is hindered by a peptide antagonist of F11R/JAM‑A protein. | Cancer Cell Int | 2023 | 37563645 | PubTator, text mining | PubMed |
| Next-generation antibody-drug conjugates for breast cancer: Moving beyond HER2 and TROP2. | Crit Rev Oncol Hematol | 2023 | 37562695 | PubTator, text mining | PubMed |
| Transcriptome sequencing reveals novel molecular features of SLE severity. | Front Genet | 2023 | 37554401 | PubTator, text mining | PubMed |
| Toxicity profile of antibody-drug conjugates in breast cancer: practical considerations. | EClinicalMedicine | 2023 | 37554126 | PubTator, text mining | PubMed |
| Targeting Trop-2 as a Cancer Driver. | J Clin Oncol | 2023 | 37549340 | PubTator, text mining | PubMed |
| Mirvetuximab Soravtansine in Platinum-Resistant Ovarian Cancer. | Clin Med Insights Oncol | 2023 | 37528890 | PubTator, text mining | PubMed |
| TROPION-Breast02: Datopotamab deruxtecan for locally recurrent inoperable or metastatic triple-negative breast cancer. | Future Oncol | 2023 | 37526149 | PubTator, text mining | PubMed |
| Apical bulkheads accumulate as adaptive response to impaired bile flow in liver disease. | EMBO Rep | 2023 | 37522754 | PubTator, text mining | PubMed |
| ICAM1 antibody drug conjugates exert potent antitumor activity in papillary and anaplastic thyroid carcinoma. | iScience | 2023 | 37520726 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4070/papers?page=52